Amedeo Smart

Free Medical Literature Service

 

Amedeo

Tuberculosis
  Free Subscription

Articles published in
Eur Respir J
    August 2025
  1. SCOPAZZINI M, Zenner D
    Tuberculosis preventive treatment in people living with HIV: to improve treatment completion, we need a simpler cascade of care.
    Eur Respir J. 2025;66:2500638.
    >> Share

  2. LANGE C, Barry C 3rd, Sotgiu G
    Linezolid for the treatment of drug-resistant tuberculosis.
    Eur Respir J. 2025;66:2500927.
    >> Share

    July 2025
  3. KWAK N, Kim JY, Han A, Berry C, et al
    Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: An individual patient data meta-analysis.
    Eur Respir J. 2025 Jul 17:2500315. doi: 10.1183/13993003.00315-2025.
    >> Share

  4. ORDONEZ AA, Willy Vangu MD, Rajaratnam A, Mofokeng N, et al
    Collagen-targeted PET/CT Imaging of Tuberculosis Patients.
    Eur Respir J. 2025 Jul 10:2500195. doi: 10.1183/13993003.00195-2025.
    >> Share

  5. DUPUIS GN, Dolynska M, Chiang SS, Horsburgh CR Jr, et al
    Risk of rifampin resistance emergence after incomplete first-line tuberculosis treatment.
    Eur Respir J. 2025 Jul 3:2500902. doi: 10.1183/13993003.00902-2025.
    >> Share

  6. MIGLIORI GB, Centis R, D'Ambrosio L, Rossato Silva D, et al
    Post Tuberculosis Lung Disease: questions and answers.
    Eur Respir J. 2025 Jul 3:2500992. doi: 10.1183/13993003.00992-2025.
    >> Share

  7. ZENNER D, Haghparast-Bidgoli H, Chaudhry T, Abubakar I, et al
    How to diagnose TB in migrants? A systematic review of reviews and decision tree analytical modelling exercise to evaluate properties for single and combined tuberculosis screening tests.
    Eur Respir J. 2025;66:2402000.
    >> Share

    June 2025
  8. TEO AKJ, Luu KB, Garden F, Pham CD, et al
    The relationship between a known diagnosis of tuberculosis and symptom reporting: implications for case detection strategies.
    Eur Respir J. 2025 Jun 26:2402521. doi: 10.1183/13993003.02521-2024.
    >> Share

  9. AKKERMAN OW, Falzon D, Migliori GB, Konstantynovska O, et al
    WHO online guide on the use of digital technologies for tuberculosis programmes.
    Eur Respir J. 2025;65:2401126.
    >> Share

    May 2025
  10. DEGTYAREVA S, Hamada Y, Baggaley RF, Hassan N, et al
    Tuberculosis Preventive Treatment care pathways in people living with HIV: a systematic review and meta-analysis.
    Eur Respir J. 2025 May 1:2302174. doi: 10.1183/13993003.02174-2023.
    >> Share

    February 2025
  11. KRAEF C, Roen A, Podlekareva D, Bakowska E, et al
    Incident tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort study.
    Eur Respir J. 2025 Feb 20:2401904. doi: 10.1183/13993003.01904-2024.
    >> Share

    January 2025
  12. CANGELOSI GA, Salfinger M
    Casting a wider net for tuberculosis cases.
    Eur Respir J. 2025;65:2402245.
    >> Share

  13. WANG Y, Cui J, Li Y, Wang M, et al
    Rapid quantitative PCR on tongue swabs for pulmonary tuberculosis in adults: a prospective multicentre study.
    Eur Respir J. 2025;65:2401493.
    >> Share

  14. LOADER MI, Vasquez Alves S, Gilman RH, Coronel J, et al
    Up-regulated matrix metalloproteinase activity in soil-transmitted helminth-tuberculosis co-infection is associated with increased lung pathology.
    Eur Respir J. 2025;65:2401445.
    >> Share

    December 2024
  15. KUNST H, Lange B, Hovardovska O, Bockey A, et al
    Tuberculosis in adult migrants in Europe: a TBnet consensus statement.
    Eur Respir J. 2024 Dec 13:2401612. doi: 10.1183/13993003.01612-2024.
    >> Share

    November 2024
  16. CHHABRA S, Koh MCY, Allen DM
    The treatment of latent tuberculosis infection in migrants in primary care versus secondary care.
    Eur Respir J. 2024;64:2401569.
    >> Share

  17. THU WPP, Loh FK, Ong CWM
    Blood RNA signatures for 8-week sputum tuberculosis culture sterilisation: how close are we?
    Eur Respir J. 2024;64:2401669.
    >> Share

    September 2024
  18. EDEM VF, Nkereuwem E, Agbla SC, Owusu SA, et al
    Accuracy of Computer-Aided Detection for Tuberculosis (R) on paediatric chest radiographs.
    Eur Respir J. 2024 Sep 3:2400811. doi: 10.1183/13993003.00811-2024.
    >> Share

  19. ROSENHEIM J, Abebe M, Belay M, Tulu B, et al
    Detection of M. tuberculosis DNA in TB contacts' PBMC does not associate with blood RNA signatures for incipient tuberculosis.
    Eur Respir J. 2024 Sep 3:2400479. doi: 10.1183/13993003.00479-2024.
    >> Share

    August 2024
  20. BURMAN M, Zenner D, Copas AJ, Gosce L, et al
    The treatment of latent tuberculosis infection in migrants in primary care versus secondary care.
    Eur Respir J. 2024 Aug 22:2301733. doi: 10.1183/13993003.01733-2023.
    >> Share

  21. GREENAN-BARRETT J, Gupta RK, Noursadeghi M
    The end of the road for blood RNA biomarkers as triage tests for symptomatic pulmonary tuberculosis among spontaneous sputum producers?
    Eur Respir J. 2024;64:2401365.
    >> Share

  22. MUWANGA VM, Mendelsohn SC, Leukes V, Stanley K, et al
    Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study.
    Eur Respir J. 2024;64:2400153.
    >> Share

  23. CALDERWOOD CJ, Sanchez Martinez A, Greenan-Barrett J, Turner CT, et al
    Resolution of tuberculosis blood RNA signatures fails to discriminate persistent sputum culture positivity after eight weeks of anti-tuberculous treatment.
    Eur Respir J. 2024 Aug 1:2400457. doi: 10.1183/13993003.00457-2024.
    >> Share

    July 2024
  24. KOSER CU, Miotto P, Ismail N, Anthony RM, et al
    A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for Mycobacterium tuberculosis complex.
    Eur Respir J. 2024;64:2400391.
    >> Share

    June 2024
  25. JANKOVIC MAKEK M, Lovric Makaric Z, Petrovic G, Sarajlic G, et al
    New priorities for Croatia to pursue tuberculosis pre-elimination.
    Eur Respir J. 2024;63:2400279.
    >> Share

    May 2024
  26. GRAY DM, Githinji L, Brittain K, Franckling-Smith Z, et al
    Lung function trajectories in South African children with pulmonary tuberculosis (TB) compared to those with non-TB lower respiratory tract infection: A prospective study.
    Eur Respir J. 2024 May 23:2400216. doi: 10.1183/13993003.00216-2024.
    >> Share

  27. MESIC A, Decuyper I, Ishaq S, Azizi T, et al
    Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based non-randomized clinical trial, Kandahar Afghanistan.
    Eur Respir J. 2024 May 23:2400436. doi: 10.1183/13993003.00436-2024.
    >> Share

    April 2024
  28. TRAUTH J, Kantelhardt V, Usenko B, Knipper M, et al
    Bedaquiline, pretomanid, and linezolid in multidrug-resistant and pre-extensively drug-resistant tuberculosis in refugees from Ukraine and Somalia in Germany.
    Eur Respir J. 2024 Apr 18:2400303. doi: 10.1183/13993003.00303-2024.
    >> Share

  29. NOGUERA-JULIAN A, Latre C, Flores A
    Availability of paediatric dispersible fixed-dose combinations of tuberculosis drugs in Spain.
    Eur Respir J. 2024;63:2400104.
    >> Share

    January 2024
  30. ALI M, El Hafid M, Farrar DS, Kourdi H, et al
    Travel-acquired paediatric tuberculosis in the Greater Toronto Area, Canada, 2002-2018.
    Eur Respir J. 2024 Jan 11:2301533. doi: 10.1183/13993003.01533-2023.
    >> Share


  31. "Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update." S. Ghosh, L. Breitscheidel, N. Lazarevic, et al. Eur Respir J 2021; 57: 2002483.
    Eur Respir J. 2024;63:2052483.
    >> Share

    November 2023
  32. ACHAR J, Seddon JA, Knight GM, Dodd PJ, et al
    Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.
    Eur Respir J. 2023 Nov 9:2300969. doi: 10.1183/13993003.00969-2023.
    >> Share

  33. PERUMAL R, Bionghi N, Nimmo C, Letsoalo M, et al
    Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: A systematic review and meta-analysis.
    Eur Respir J. 2023 Nov 9:2300639. doi: 10.1183/13993003.00639-2023.
    >> Share

  34. ZENNER D, Cobelens F, Abubakar I
    Reply: Tuberculosis screening in migrants to the EU/EEA and UK.
    Eur Respir J. 2023;62:2301535.
    >> Share

  35. KOHLER N, Vasiliu A, Mandalakas AM, Martinez L, et al
    Tuberculosis screening in migrants to the EU/EEA and UK.
    Eur Respir J. 2023;62:2301230.
    >> Share

  36. DIEL R, Schluger NW
    Long-term outcome of co-infection of COVID-19 and tuberculosis: the "cursed duet".
    Eur Respir J. 2023;62:2301881.
    >> Share

  37. CASCO N, Jorge AL, Palmero DJ, Alffenaar JW, et al
    Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.
    Eur Respir J. 2023;62:2300925.
    >> Share

    October 2023
  38. DEN BOON S, Yedilbayev A
    Screening for tuberculosis among migrants in Europe: harmonising approaches during a humanitarian crisis?
    Eur Respir J. 2023;62:2301537.
    >> Share

  39. AGUIAR SOARES K, Ehrlich J, Camara M, Chaloub S, et al
    Implementation of WHO guidelines on urine lateral flow LAM testing in high TB/HIV burden African countries.
    Eur Respir J. 2023;62:2300556.
    >> Share

  40. ZENNER D, Brals D, Nederby-Ohd J, Menezes D, et al
    Drivers determining tuberculosis disease screening yield in four European screening programmes: a comparative analysis.
    Eur Respir J. 2023;62:2202396.
    >> Share

    September 2023
  41. RIOU C, du Bruyn E, Kim GHJ, da Costa I, et al
    Derivation of a high-resolution CT-based, semi-automated radiographic score in tuberculosis and its relationship to bacillary load and antitubercular therapy.
    Eur Respir J. 2023 Sep 7:2300600. doi: 10.1183/13993003.00600-2023.
    >> Share

  42. BYRNE A, Allwood B, Schoeman I, Johnston J, et al
    "Post tuberculosis": the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials.
    Eur Respir J. 2023;62:2300950.
    >> Share

    August 2023
  43. STOCKER SL, Alffenaar JC
    Predicting early bactericidal activity using pre-clinical data for tuberculosis drugs: a platform for model-informed drug discovery and development.
    Eur Respir J. 2023;62:2301108.
    >> Share

  44. ERNEST JP, Goh JJN, Strydom N, Wang Q, et al
    Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs.
    Eur Respir J. 2023;62:2300165.
    >> Share

    June 2023
  45. MIGLIORI GB, Dowdy D, Denholm JT, D'Ambrosio L, et al
    The path to tuberculosis elimination: a renewed vision.
    Eur Respir J. 2023;61:2300499.
    >> Share


  46. June Podcast: Path to tuberculosis elimination.
    Eur Respir J. 2023;61:23E6106.
    >> Share

    May 2023
  47. KOSER CU, Maurer FP
    Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for Mycobacterium tuberculosis complex.
    Eur Respir J. 2023;61:2202397.
    >> Share


  48. Reply: Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis.
    Eur Respir J. 2023;61:2300426.
    >> Share

  49. KAHLMETER G, Turnidge J
    The determination of epidemiological cut-off values requires a systematic and joint approach based on quality controlled, non-truncated minimum inhibitory concentration series.
    Eur Respir J. 2023;61:2202259.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016